CSI Market
Sign In | Register

Burning Rock Biotech Limited (BNR) Quarterly Income Statement

Quarterly · GAAP · USD millions
Access BNR Annual Income Statement →
The data below summarizes Burning Rock Biotech Limited's income statement results from Dec 31 2024 to Dec 31 2025, enabling period-by-period comparison of operating performance.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
Q4 2025 		0 0 0 (Dec 31 2024)
Revenues
Total Revenue77.16
Costs & Expenses
Cost of Goods and Services Sold19.54
Gross Profit57.62
Selling, Administration, Marketing23.62
Research and Development Expense23.81
Impairment of Long-Lived Assets to be Disposed of0.00
Other Operating Expense / -Income18.03
Total operating costs including COS85.00
Operating income / -loss-7.84
Interest Expense0.00
Net Interest Expense / -Income0.00
Foreign Currency Transaction Gain (Loss), before Tax-0.96
Other loss / -income0.81
Total costs & expenses84.85
Income & Taxes
Income / -loss before income taxes-7.69
Income taxes expenses / -benefit0.22
Income after income taxes-7.92
Net income / -loss of other equity0.00
Income / -loss from continuing operations-7.92
Net income / -loss-7.92
Income / -loss to shareholder-7.92
EBIT-7.70
EBITD-4.61
EBITDA-4.59
Earnings Per Share
Basic EPS (excl. extra items)0.00
Basic Net EPS0.00
Diluted Net EPS0.00
4 historic quarters locked

Sign in to unlock the full Burning Rock Biotech Limited income statement history.

Sign In Create Free Account

About BNR Quarterly Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-Q filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-Q filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.